FDA Rejects Endo Testosterone Drug For 3rd Time
The U.S. Food and Drug Administration has again refused to approve Endo Health Solutions Inc.'s testosterone replacement injection Aveed and has requested additional risk information before considering the drug a fourth...To view the full article, register now.
Already a subscriber? Click here to view full article